ETON PHARMACEUTICALS

Eton Pharmaceuticals Announces Sale of Hospital Products

24 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2022 Financial Results

12 May 2022 16:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

03 May 2022 16:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

11 Apr 2022 16:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

11 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2021 Financial Results

16 Mar 2022 16:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2021 Financial Results on Wednesday, March 16, 2022

08 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)

20 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter Financial Results

15 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®

15 Nov 2021 06:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral Solution

08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

03 Nov 2021 16:15:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid

28 Oct 2021 07:30:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter Financial Results

16 Aug 2021 16:02:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

03 Aug 2021 16:05:02 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector

15 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)

15 Jun 2021 10:37:52 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter from U.S. FDA for Dehydrated Alcohol Injection

28 May 2021 08:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Record Revenue and Earnings

13 May 2021 16:05:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

04 May 2021 16:05:01 By Nasdaq GlobeNewswire